Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Androgen receptors help prostate cancer cells grow and resist drugs.

New compounds were made that are promising for prostate cancer therapy.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Analog 23 is a promising compound for prostate cancer treatment.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.